BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14507648)

  • 1. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.
    Heselmeyer-Haddad K; Janz V; Castle PE; Chaudhri N; White N; Wilber K; Morrison LE; Auer G; Burroughs FH; Sherman ME; Ried T
    Am J Pathol; 2003 Oct; 163(4):1405-16. PubMed ID: 14507648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain of 3q26: a genetic marker in low-grade squamous intraepithelial lesions (LSIL) of the uterine cervix.
    Seppo A; Jalali GR; Babkowski R; Symiakaki H; Rodolakis A; Tafas T; Tsipouras P; Kilpatrick MW
    Gynecol Oncol; 2009 Jul; 114(1):80-3. PubMed ID: 19394683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
    Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
    Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic amplification of the human telomerase RNA gene for differential diagnosis of cervical disorders.
    Tu Z; Zhang A; Wu R; Jiang J; Li Y; Wulan N; Li J; Zhang Y; Li Y; Chen Z; Wei L
    Cancer Genet Cytogenet; 2009 May; 191(1):10-6. PubMed ID: 19389503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
    Heselmeyer-Haddad K; Sommerfeld K; White NM; Chaudhri N; Morrison LE; Palanisamy N; Wang ZY; Auer G; Steinberg W; Ried T
    Am J Pathol; 2005 Apr; 166(4):1229-38. PubMed ID: 15793301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
    Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
    Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of genomic amplification of the human telomerase RNA component gene in the screening of cervical lesions].
    Jiang J; Tu Z; Zhang G; Li JR; Zhao LJ; Zhao C; Cui SH; Li XP; Chen Z; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):849-53. PubMed ID: 19087570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions.
    Kokalj-Vokac N; Kodric T; Erjavec-Skerget A; Zagorac A; Takac I
    Cancer Genet Cytogenet; 2009 Nov; 195(1):19-22. PubMed ID: 19837263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human telomerase RNA gene (TERC) gain and polysomy of chromosome 3 in cervicovaginal liquid-based pap preparations: a fluorescence in situ hybridization study.
    Sui W; Ou M; Chen J; Yu J; Zhang Y; Lan H; Huang H; Dai Y
    Eur J Gynaecol Oncol; 2010; 31(4):375-9. PubMed ID: 20882876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application of telomerase RNA component gene amplification assay in cervical lesions.].
    Jiang J; Wei LH; Wu RF; Zhang G; Wulan N; Li JR; Li YB; Tu Z; Zhou YQ; Zhao Y; Chen Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):883-6. PubMed ID: 20193412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.
    Andersson S; Sowjanya P; Wangsa D; Hjerpe A; Johansson B; Auer G; Gravitt PE; Larsson C; Wallin KL; Ried T; Heselmeyer-Haddad K
    Am J Pathol; 2009 Nov; 175(5):1831-47. PubMed ID: 19880826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
    Sui W; Ou M; Dai Y; Chen J; Lan H; Yan Q; Huang H
    Int J Gynecol Cancer; 2009 Nov; 19(8):1303-6. PubMed ID: 20009881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
    Wright TC; Compagno J; Romano P; Grazioli V; Verma Y; Kershnar E; Tafas T; Kilpatrick MW
    Am J Obstet Gynecol; 2015 Jul; 213(1):51.e1-51.e8. PubMed ID: 25659466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the human telomerase gene in liquid-based preparations is associated with cervical dysplasia and carcinoma.
    Fan YB; Wu X; Fu ZM; Wu GP
    Int J Gynecol Pathol; 2010 Mar; 29(2):157-64. PubMed ID: 20173501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic amplification of hTERC in paraffin-embedded tissues of cervical intraepithelial neoplasia and invasive cancer.
    He C; Xu C; Xu M; Yuan Y; Sun Y; Zhao H; Zhang X
    Int J Gynecol Pathol; 2012 May; 31(3):280-5. PubMed ID: 22498947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
    Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J
    Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.
    Jin Y; Li JP; He D; Tang LY; Zee CS; Guo SZ; Zhou J; Chen JN; Shao CK
    Asian Pac J Cancer Prev; 2011; 12(5):1167-71. PubMed ID: 21875260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.